Navigation Links
Novel Protein, Staufen2 Important In Maintenance Of Nerve Synapses

Researchers from Max Plank Institute of Developmental Biology have uncovered some of the molecular mysteries associated with synaptic connections between the neurons, that represent the structural and functional unit of the brain. //

In simple terms, the junction between two neurons is referred to as a synapse. It serves as a gateway of communication between the same. Storage and transmission of information occurs through these specialized contact sites. This synaptic connection is of great importance in the process of learning and remembering what has been learnt. These is a parallel change in the structural and functional characteristics of the synaptic junctions during the learning process. The exact molecular mechanism behind this modification has been largely unknown until now.

Michael Kiebler and his colleagues have now identified a protein called, Staufen2, found to play a significant role in the mainatenance of synaptic junctions. A cell devoid of this protein would lose a significant proportion of the synapses. Associated impairment in other contact sites and the signalling mechanism have also been identified.

The protein is known to be invloved in the transport of mRNAs to to specific locations inside a cell. This has been found to largely dependent on the recognition of the mRNA by special RNA binding proteins and the subsequent transport to synaptic junctions. As any defect in this process (due to missing Staufen2 protein) has been found to result in structural and functional inhibition of the synapse, it is logical to assume that the protein also plays a major role in the process of learning and memory retention.

This finding has obviously led to a better understanding of the molecular mechanisms behind the ability of the brain to learn and remember. If in the future, such mechanisms can be manipulated, it could lead to a revolution. Somebody who has a poor learning capacity can be substituted with an ‘ideal brain’. This could go a long way in the treatment of disorders related to learning and memory function.


'"/>




Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
Breaking Medicine Technology: